SOX2 and colorectal cancer: In summary, we demonstrated that silencing SOX2 could induce a mesenchymal-epithelial transition in colorectal cancer cells, which partially explain the observation that SOX2 knock down lowered cell mobility and invasion ability in vitro and reduce metastasis in vivo.